1. Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives

   • Rebecca Moore
   • Joshua Poulsen
   • Jane B. Lane

   Commentary Open access 20 February 2024 Pages: 1305 - 1317

2. Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys

   • Pamela R. Kushner
   • Jane DeMeis
   • Navdeep Tangri

   Commentary Open access 05 March 2024 Pages: 1318 - 1324

   

3. Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review

   • Natalie V. J. Aldhouse
   • Helen Kitchen
   • Christine L. Baker

   Review Open access 16 February 2024 Pages: 1325 - 1337

   

4. Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy

   • LeighAnn Y. Vincik
   • Alexandra D. Dautel
   • Alan D. Kaye

   Review 20 February 2024 Pages: 1338 - 1350

   

5. An Update on Stiripentol Mechanisms of Action: A Narrative Review

   • Alexandre Bacq
   • Antoine Depaulis
   • Marc Verleye

   Review Open access 05 March 2024 Pages: 1351 - 1371

   

6. Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus

   • José Manuel Carrascosa
   • Ana Echarri
   • María Montoro Álvarez

   Original Research 07 February 2024 Pages: 1372 - 1384

   

7. Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy

   • Carla Rognoni
   • Domenica Lorusso
   • Patrizio Armeni

   Original Research Open access 08 February 2024 Pages: 1385 - 1400

   

8. Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma

   • Andrea Bever
   • Jessica Dunne
   • Shelagh M. Szabo

   Original Research 13 February 2024 Pages: 1401 - 1418

   

9. Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study

   • Adel Alharbi
   • Abdullah Yousef
   • Matthieu Beuvelet

   Original Research Open access 15 February 2024 Pages: 1419 - 1435

   

10. Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective

    • Fuming Li
    • Yingyao Chen
    • Yi Yang

    Original Research 15 February 2024 Pages: 1436 - 1449

    

11. Application of Northern Goshawk Back-Propagation Artificial Neural Network in the Prediction of Monohydroxycarbazepine Concentration in Patients with Epilepsy

    • Yichao Xu
    • Rong Shao
    • Haibin Dai

    Original Research 15 February 2024 Pages: 1450 - 1461

    

12. Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome

    • Mona Darwish
    • Julie Passarell
    • Kathie M. Bishop

    Original Research Open access 16 February 2024 Pages: 1462 - 1480

    

13. 7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage

    • Fritz H. Hengerer
    • Gerd U. Auffarth
    • Ina Conrad-Hengerer

    Original Research Open access 16 February 2024 Pages: 1481 - 1495

    

14. Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study

    • Rajesh Parekh
    • Billy R. Hammond Jr.
    • Divya Chandradhara

    Original Research Open access 16 February 2024 Pages: 1496 - 1511

    

15. Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis

    • Alissa Rams
    • Jessica Baldasaro
    • Evangeline Pierce

    Original Research Open access 16 February 2024 Pages: 1512 - 1525

    

16. Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan

    • Takayuki Hamano
    • Yusuke Yamaguchi
    • Tadao Akizawa

    Original Research Open access 16 February 2024 Pages: 1526 - 1552

    

17. Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials

    • Takayuki Hamano
    • Yusuke Yamaguchi
    • Jonathan Barratt

    Original Research Open access 16 February 2024 Pages: 1553 - 1575

    

18. Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

    • Hermann Einsele
    • Philippe Moreau
    • Maria-Victoria Mateos

    Original Research Open access 24 February 2024 Pages: 1576 - 1593

    

19. Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands

    • Juul M. P. A. van den Reek
    • Robert J. T. van der Leest
    • Elke M. G. J. de Jong

    Original Research 24 February 2024 Pages: 1594 - 1605

    

20. Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis

    • André L. F. Azeredo-da-Silva
    • Victor Hugo F. de Jesus
    • Patricia K. Ziegelmann

    Original Research Open access 26 February 2024 Pages: 1606 - 1620

    

21. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer

    • Yan Li
    • Shengjie Yang
    • Xinghe Wang

    Original Research 29 February 2024 Pages: 1621 - 1636

    

22. Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies

    • Nandita Khera
    • Marie Louise Edwards
    • Usama Gergis

    Original Research Open access 01 March 2024 Pages: 1637 - 1651

    

23. Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)

    • Seung-June Oh
    • Sung Tae Cho
    • Budiwan Sumarsono

    Original Research Open access 02 March 2024 Pages: 1652 - 1671

    

24. Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab

    • Sanjay Chabra
    • Julie Birt
    • W. Chad Cragun

    Original Research Open access 05 March 2024 Pages: 1672 - 1684

    

25. Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome

    • Hyun-Jin Kim
    • Hyun-Sun Kim

    Original Research 05 March 2024 Pages: 1685 - 1697

    

26. Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis

    • Yue Pan
    • Xinxin Zhang
    • Lei Cheng

    Original Research 05 March 2024 Pages: 1698 - 1710

    

27. Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study

    • Daniel J. Simmons
    • Stephen J. Valerio
    • Janvi Sah

    Original Research Open access 05 March 2024 Pages: 1711 - 1727

    

28. Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study

    • Motohiro Ozone
    • Susumu Hirota
    • Naohisa Uchimura

    Original Research Open access 09 March 2024 Pages: 1728 - 1745

    

29. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials

    • Brian Moseley
    • Dimitrios Bourikas
    • Simon Borghs

    Brief Report Open access 15 February 2024 Pages: 1746 - 1758

    

30. Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”

    • Kun Huang

    Letter Open access 10 February 2024 Pages: 1759 - 1761

31. A Response to: Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”

    • Congling Gu
    • Yi Han

    Letter Open access 10 February 2024 Pages: 1762 - 1764

32. Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia

    • Tawfeg Ben-Omran
    • Luis Masana
    • Raul D. Santos

    Correction Open access 20 February 2024 Pages: 1765 - 1769

    

33. Correction to: Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients’ Real-World Insights for Optimizing Outcomes

    • Bruce A. Cowan
    • Kara Olivier
    • Jeffrey S. Wefel

    Correction Open access 11 January 2024 Pages: 1770 - 1773

    

34. Correction to: Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs

    • Sana Niazi
    • Zisis Gatzioufas
    • Farideh Doroodgar

    Correction 02 March 2024 Pages: 1774 - 1774